Cannabidiol efficacy independent of clobazam: Meta‐analysis of four randomized controlled trials

OBJECTIVE: The efficacy of cannabidiol (CBD) with and without concomitant clobazam (CLB) was evaluated in stratified analyses of four large randomized controlled trials, two in Lennox‐Gastaut syndrome, and two in Dravet syndrome. METHODS: Each trial of CBD (Epidiolex(®) in the US; Epidyolex(®) in th...

Descripción completa

Detalles Bibliográficos
Autores principales: Devinsky, Orrin, Thiele, Elizabeth A, Wright, Stephen, Checketts, Daniel, Morrison, Gilmour, Dunayevich, Eduardo, Knappertz, Volker
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689899/
https://www.ncbi.nlm.nih.gov/pubmed/32592183
http://dx.doi.org/10.1111/ane.13305

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689899/
https://www.ncbi.nlm.nih.gov/pubmed/32592183
http://dx.doi.org/10.1111/ane.13305

Ejemplares similares